Francesca Magrinelli,Christelle Tesson,Plamena R. Angelova,Ainara Salazar-Villacorta,Jose A. Rodriguez,Annarita Scardamaglia,Brian Hon-Yin Chung,Matthew Jaconelli,Barbara Vona,Noemi Esteras,Anna Ka-Yee Kwong,Thomas Courtin,Reza Maroofian,Shahryar Alavi,Raja Nirujogi,Mariasavina Severino,Patrick A. Lewis,Stephanie Efthymiou,Benjamin O'Callaghan,Rebecca Buchert,Linda Sofan,Pawel Lis,Chloé Pinon,Guido J. Breedveld,Martin Man-Chun Chui,David Murphy,Vanessa Pitz,Mary B. Makarious,Marlene Cassar,Bassem A. Hassan,Sana Iftikhar,Clarissa Rocca,Peter Bauer,Michele Tinazzi,Marina Svetel,Bedia Samanci,Haşmet A. Hanağasi,Basar Bilgiç,José A. Obeso,Monica M. Kurtis,Guillaume Cogan,Ayşe Nazli Başak,Güneş Kiziltan,Tuğçe Gül,Gül Yalçin,Bülent Elibol,Nina Barišić,Earny Wei-Sen Ng,Sze-Shing Fan,Tova Hershkovitz,Karin Weiss,Javeria Raza Alvi,Tipu Sultan,Issam Azmi Alkhawaja,Tawfiq Froukh,Hadeel Abdollah E Alrukban,Christine Fauth,Ulrich A. Schatz,Thomas Zöggler,Michael Zech,Karen Stals,Vinod Varghese,Sonia Gandhi,Cornelis Blauwendraat,John A. Hardy,Suzanne Lesage,Vincenzo Bonifati,Tobias B. Haack,Aida M. Bertoli-Avella,Robert Steinfeld,Dario R. Alessi,Hermann Steller,Alexis Brice,Andrey Y. Abramov,Kailash P. Bhatia,Henry Houlden

Abstract:Dissecting biological pathways highlighted by Mendelian gene discovery has provided critical insights into the pathogenesis of Parkinson's disease (PD) and neurodegeneration. This approach ultimately catalyzes the identification of potential biomarkers and therapeutic targets. Here, we identify as a new gene implicated in PD and childhood neurodegeneration. We find that biallelic missense and loss-of-function variants co-segregate with phenotypes from early-onset PD and parkinsonism to perinatal lethality with neurological manifestations across 15 unrelated pedigrees with 22 affected subjects, showing clear genotype-phenotype correlation. encodes the proteasome regulator PSMF1/PI31, a highly conserved, ubiquitously expressed partner of the 20S proteasome and neurodegeneration-associated F-box-O 7 and valosin-containing proteins. We demonstrate that variants impair mitochondrial membrane potential, dynamics and mitophagy in patient-derived fibroblasts. Additionally, we develop models of knockdown and conditional knockout mouse exhibiting age-dependent motor impairment, with diffuse gliosis in mice. These findings unequivocally link defective PSMF1 to early-onset PD and neurodegeneration and suggest mitochondrial dysfunction as a mechanistic contributor.

What problem does this paper attempt to address?

This paper aims to address a series of neurodegenerative diseases caused by variations in the PSMF1 gene. Specifically, the study found that biallelic missense and loss-of-function variants of the PSMF1 gene are associated with a range of phenotypes, from early-onset Parkinson's disease (PD) to perinatal lethality. These phenotypes include early-onset Parkinson's disease, movement disorders, neurodevelopmental delay, and severe perinatal neurological abnormalities. Through extensive genomic data analysis and functional validation, the paper identifies the role of the PSMF1 gene in these diseases, particularly its impact on mitochondrial function. Researchers observed a decrease in mitochondrial membrane potential, altered dynamics, and autophagy dysfunction due to PSMF1 deficiency using live-cell imaging techniques in patient-derived fibroblasts. Additionally, by constructing Drosophila and mouse models, they further confirmed that PSMF1 gene variants lead to age-dependent movement disorders and observed diffuse gliosis in the mouse model. In summary, this study not only reveals the critical role of the PSMF1 gene in early-onset Parkinson's disease and other early neurodegenerative diseases but also provides new perspectives for the diagnosis, biomarker discovery, and potential therapeutic strategies for these diseases.

variants cause a phenotypic spectrum from early-onset Parkinson's disease to perinatal lethality by disrupting mitochondrial pathways